AMRX
AMRX
Positions held
Your positionsAMRX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Amneal to Report Third Quarter 2026 Results on November 3, 2026
2026-10-05 · 3 Low-Volatility Stocks with Open Questions
2026-10-03 · Amneal Pharmaceuticals (AMRX) Stock Gets Fair Value Bump After Analyst Backing For New Launches
2026-09-22 · Why Is Amneal (AMRX) Stock Rocketing Higher Today
2026-09-21 · Ipsen Shares Fall After Early Launch of U.S. Generic Rival
2026-09-18 · Amneal Announces FDA Approval and Launch of Lanreotide Injection
2026-09-18 · 3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
2026-09-17 · Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains?
2026-09-05 · Does Amneal’s Post‑Earnings Shelf Registration Reshape the Bull Case for Amneal Pharmaceuticals (AMRX)?
2026-09-04 · Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats
2026-09-04 · Amneal Pharmaceuticals (AMRX) Stock Sees Modest Fair Value Lift On Launch Optimism
2026-09-03 · Generic Pharmaceuticals Stocks Q2 Results: Benchmarking Amneal (NASDAQ:AMRX)
Price (daily)
Full chart · RSI · MACD · patterns